C07K 14/35
From mycobacteriaceae
Official title: from Mycobacteriaceae (F)
C07K14/35 (From mycobacteriaceae) appears on 649 US grants and 682 published applications in this corpus.
Search patents in C07K- Granted patents
- 649
- Published applications
- 682
- Assignees
- 357
- Inventors
- 1,190
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 3 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 3 | 0 |
| 1991 | 0 | 0 |
| 1992 | 4 | 0 |
| 1993 | 4 | 0 |
| 1994 | 3 | 0 |
| 1995 | 2 | 0 |
| 1996 | 11 | 0 |
| 1997 | 14 | 0 |
| 1998 | 30 | 0 |
| 1999 | 26 | 0 |
| 2000 | 17 | 0 |
| 2001 | 24 | 4 |
| 2002 | 27 | 30 |
| 2003 | 29 | 40 |
| 2004 | 13 | 38 |
| 2005 | 11 | 29 |
| 2006 | 23 | 34 |
| 2007 | 19 | 24 |
| 2008 | 11 | 22 |
| 2009 | 22 | 31 |
| 2010 | 27 | 31 |
| 2011 | 35 | 33 |
| 2012 | 21 | 29 |
| 2013 | 30 | 28 |
| 2014 | 16 | 28 |
| 2015 | 21 | 24 |
| 2016 | 18 | 24 |
| 2017 | 25 | 36 |
| 2018 | 23 | 19 |
| 2019 | 27 | 21 |
| 2020 | 21 | 18 |
| 2021 | 14 | 27 |
| 2022 | 11 | 25 |
| 2023 | 17 | 22 |
| 2024 | 17 | 28 |
| 2025 | 17 | 20 |
| 2026 | 6 | 17 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Diagnostic reagents4 Aug 2026US 12,699,090 B2The Penn State Research Foundation
- Analyte sequencing with nanopores21 Jul 2026US 12,687,517 B2University of Washington
- Fluorescent protein sensor capable of quantitatively measuring oxidation degree of methionine residues of specific protein, and use thereof21 Jul 2026US 12,687,545 B2Geronmed, Co. Ltd
- Therapeutic efficacy by pulmonary delivery of live attenuated mycobacteria17 Feb 2026US 12,551,512 B2Universidad De Zaragoza
- HSP fusion protein with anti-chemorepellant agent for treatment of cancer3 Feb 2026US 12,540,165 B2The General Hospital Corporation
- Rna for preventing or treating tuberculosis24 Sep 2026US 2026/0284168 A1
- Tuberculosis vaccine composition containing immune-active site fusion protein10 Sep 2026US 2026/0263577 A1Myco-Rapha Inc.
- Il-15-based molecules and methods of use thereof3 Sep 2026US 2026/0256886 A1Altor BioScience Corporation
- Method for the treatment of allergic rhinitis20 Aug 2026US 2026/0242429 A1Revolo Biotherapeutics Limited
- Anti-tuberculosis vaccine targeting selected mycobacterium tuberculosis protective antigens to dendritic cells6 Aug 2026US 2026/0226183 A1Assistance Publique-HôPitaux De Paris (Aphp)
Most cited
By later US patents
- Polynucleotide tuberculosis vaccine133US 5,736,524 AMerck & Co., Inc. · 1998
- Methods for capture and selective release of nucleic acids using weakly basic polymer and amplification of same124US 5,582,988 AJohnson & Johnson Clinical Diagnostics, Inc. · 1996
- Methods of amplifying nucleic acids using promoter-containing primer sequence115US 5,766,849 AGen-Probe Incorporated · 1998
- Avirulent microbes and uses therefor: Salmonella typhi109US 5,387,744 AWashington University · 1995
- Avirulent microbes and uses therefor: salmonella typhi103US 5,294,441 AWashington University · 1994